Brief: China Biotech Services Says QTRLY Profit Hk$81.8 Million Versus Loss Of Hk$21.1 Million
12/08/2021 16:09
Aug 12 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* QTRLY PROFIT HK$81.8 MILLION VERSUS LOSS OF HK$21.1
MILLION
* QTRLY TURNOVER HK$220.0 MILLION VERSUS HK$18.6 MILLION
* WILL INITIATE MORE INTERNATIONAL COLLABORATION, INCLUDING
OVERSEAS REGISTRATIONS IN RESPECT OF IMMUNE CELL DRUG RESEARCH
Source text for Eikon: ID:nHKSc5kP5z
Further company coverage: 8037.HK
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)